CLINICAL_TRIALS
trial_result
· 2020-03-23
Clinical Trial Update: The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency [Phase 2]
Summary
Phase 2 trial update evaluating the efficacy and safety of Zhigancao Tang Granule for heart failure with preserved ejection fraction due to Qi-Yin deficiency.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: UNKNOWN